<VariationArchive VariationID="2579185" VariationName="GRCh38/hg38 16p13.3(chr16:3818098-3858843)x1" VariationType="copy number loss" Accession="VCV002579185" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2744223" VariationID="2579185">
      <GeneList>
        <Gene Symbol="CREBBP" FullName="CREB binding protein" GeneID="1387" HGNC_ID="HGNC:2348" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3725054" stop="3880713" display_start="3725054" display_stop="3880713" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3775054" stop="3930120" display_start="3775054" display_stop="3930120" Strand="-" />
          </Location>
          <OMIM>600140</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CREBBP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CREBBP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GRCh38/hg38 16p13.3(chr16:3818098-3858843)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3818098" stop="3858843" display_start="3818098" display_stop="3858843" variantLength="40746" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh38/hg38 16p13.3(chr16:3818098-3858843)x1 AND Rubinstein-Taybi syndrome due to CREBBP mutations" Accession="RCV003327624" Version="3">
        <ClassifiedConditionList TraitSetID="1898">
          <ClassifiedCondition DB="MedGen" ID="C4551859">Rubinstein-Taybi syndrome due to CREBBP mutations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20583168</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31690835</ID>
          <ID Source="pmc">7313390</ID>
          <ID Source="DOI">10.1038/s41436-019-0686-8</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34740920</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1898" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4360" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rubinstein-Taybi syndrome due to CREBBP mutations</ElementValue>
                <XRef ID="MONDO:0008393" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rubinstein syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Broad thumbs and great toes, characteristic facies, and mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rubinstein-Taybi syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RUBINSTEIN-TAYBI SYNDROME 1, INCOMPLETE</ElementValue>
                <XRef Type="Allelic variant" ID="600140.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600140.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CREBBP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RSTS1</ElementValue>
                <XRef Type="MIM" ID="180849" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CREBBP-Related Rubinstein-Taybi Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Rubinstein-Taybi syndrome (RSTS) is characterized by distinctive facial features, broad and often angulated thumbs and halluces, short stature, and moderate-to-severe intellectual disability. The characteristic craniofacial features are downslanted palpebral fissures, low-hanging columella, high palate, grimacing smile, and talon cusps. Prenatal growth is often normal, then height, weight, and head circumference percentiles rapidly drop in the first few months of life. Short stature is typical in adulthood. Obesity may develop in childhood or adolescence. Average IQ ranges between 35 and 50; however, developmental outcome varies considerably. Some individuals with EP300-RSTS have normal intellect. Additional features include ocular abnormalities, hearing loss, respiratory difficulties, congenital heart defects, renal abnormalities, cryptorchidism, feeding problems, recurrent infections, and severe constipation.</Attribute>
                <XRef ID="NBK1526" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17534" />
                <XRef ID="17534" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301699</ID>
                <ID Source="BookShelf">NBK1526</ID>
              </Citation>
              <XRef ID="353277" DB="Orphanet" />
              <XRef ID="783" DB="Orphanet" />
              <XRef ID="C4551859" DB="MedGen" />
              <XRef ID="MONDO:0008393" DB="MONDO" />
              <XRef Type="MIM" ID="180849" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7549694" SubmissionDate="2023-09-11" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="VCGS_FAM25|OMIM:180849|copy:1|refcopy:2" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004034275" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
          <Comment>A confirmed de novo heterozygous deletion of exon 2 in CREBBP (NM_004380.3) was identified by exome sequencing and confirmed by targeted chromosomal microarray of the CREBBP gene in one individual with Rubinstein-Taybi syndrome ([GRCh38] chr16:3818098_3858843x1)(PMID: 34740920). The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. This exon deletion has also been reported in the literature in one individual with Rubinstein-Taybi syndrome (PMID: 20583168). This intragenic variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at exon 2 and leads to a premature termination codon. This alteration is then predicted to lead to a truncated or absent. The CREBBP gene is known to be haploinsufficient, and has been assessed by the ClinGen Dosage Sensitivity Working Group (https://search.clinicalgenome.org/kb/gene-dosage). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Rubinstein-Taybi syndrome. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.90 points, 3: 0 points, 4-5: 0.25 points; Total: 1.20 points; Riggs 2020 (PMID: 31690835).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">34740920</ID>
            </Citation>
            <Citation>
              <ID Source="PubMed">20583168</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CREBBP" />
          </GeneList>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="16" start="3818098" stop="3858843" variantLength="40746" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180849" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13816677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7549694" TraitType="Disease" MappingType="XRef" MappingValue="180849" MappingRef="OMIM">
        <MedGen CUI="C4551859" Name="Rubinstein-Taybi syndrome due to CREBBP mutations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

